Related Experiment Video
Updated: Apr 28, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
23.8K
Genetic prediction of future type 2 diabetes
Valeriya Lyssenko1, Peter Almgren, Dragi Anevski
1Department of Clinical Sciences, Diabetes and Endocrinology, Lund University, University Hospital Malmö, Malmö, Sweden. Valeri.Lyssenko@med.lu.se
Plos Medicine
|June 16, 2007
Summary
Genetic variants in PPARG and CAPN10 genes predict future Type 2 diabetes (T2D) risk. This genetic testing may identify individuals at high risk for developing T2D.
Area of Science:
- Genetics
- Metabolic Diseases
- Epidemiology
Background:
- Type 2 diabetes (T2D) is a complex disease influenced by genetic and environmental factors.
- While common genetic variants are linked to T2D, their prospective predictive power is not well understood.
Purpose of the Study:
- To investigate the predictive ability of common genetic variants for Type 2 diabetes (T2D) in a prospective cohort.
- To assess the combined effect of genetic risk variants and clinical factors in T2D prediction.
Main Methods:
- A Cox proportional hazard model was used to analyze data from 2,293 individuals in the Botnia study.
- Common variants in PPARG, CAPN10, KCNJ11, UCP2, and IRS1 genes were examined for T2D prediction over a median follow-up of 6 years.
Main Results:
- Variants in PPARG (P12A) and CAPN10 (SNP44) were associated with an increased risk of developing T2D.
- A combination of PPARG and CAPN10 risk genotypes significantly elevated T2D risk.
- In individuals with elevated fasting plasma glucose and high BMI, the combination of PPARG and CAPN10 risk genotypes resulted in a 21.2-fold increased hazard ratio for T2D.
Conclusions:
- Common variants in PPARG and CAPN10 genes are significant predictors of future Type 2 diabetes (T2D).
- Genetic testing for these variants could become a valuable tool for identifying individuals at high risk of T2D.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:12Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
01:26Type I Diabetes II: Pathophysiology
68
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
68
01:26Type II Diabetes I: Introduction
13
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
13
01:24Type II Diabetes II: Pathophysiology
23
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
23
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
14
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
14